menu
    • menu

    Company profile for MEDIMETRIKS PHARMS

    NEW Drugs in Dev: 1
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medimetriks is a leading independent specialty pharmaceutical company dedicated to the Dermatology and Podiatry markets. We are committed to advancing patient care through the development, licensing and commercialization of innovative prescription skincare brands that fill unmet needs in the markets we serve. Our current portfolio of brands, which are promoted by our national sales force, treat conditions including acne, r...
    Medimetriks is a leading independent specialty pharmaceutical company dedicated to the Dermatology and Podiatry markets. We are committed to advancing patient care through the development, licensing and commercialization of innovative prescription skincare brands that fill unmet needs in the markets we serve. Our current portfolio of brands, which are promoted by our national sales force, treat conditions including acne, rosacea, atopic dermatitis, fungal infections, dystrophic nails and impetigo.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MEDIMETRIKS PHARMSUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    14 Sylvan Way Suite C Parsippany, NJ 07054
    Telephone
    Telephone
    +1 973 882 7512
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medimetriks.com/contact-us
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medimetriks' MM36 Development Program Streamlined Following FDA Meeting
    Medimetriks' MM36 Development Program Streamlined Following FDA Meeting

    18 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/medimetriks-mm36-difamilast-atopic-dermatitis-development-program-streamlined-following-fda-meeting/

    BIOSPACE
    18 Sep 2020
    Share Share
    Medimetriks Announces that Otsuka Achieved +ve Top-Line Ph3 Results for MM36
    Medimetriks Announces that Otsuka Achieved +ve Top-Line Ph3 Results for MM36

    26 Mar 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/medimetriks-announces-that-otsuka-achieved-positive-top-line-phase-3-results--for-mm36-difamilast-in-japanese-adult-and-pediatric-atopic-dermatitis-patients-301030094.html

    PRNEWSWIRE
    26 Mar 2020
    Share Share
    Medimetriks Pharmaceuticals, Inc. Submits NDA to FDA for Ozenoxacin Cream
    Medimetriks Pharmaceuticals, Inc. Submits NDA to FDA for Ozenoxacin Cream

    28 Jun 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/medimetriks-pharmaceuticals-inc-submits-a-new-drug-application-to-fda-for-ozenoxacin-cream-1-a-novel-impetigo-treatment-300290327.html

    PR NEWSWIRE
    28 Jun 2016
    Share Share
    Otsuka Licenses Pre-Phase 3 Topical Atopic Dermatitis Treatment to Medimetriks
    Otsuka Licenses Pre-Phase 3 Topical Atopic Dermatitis Treatment to Medimetriks

    08 Feb 2016

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/otsuka-licenses-pre-phase-3-topical-atopic-dermatitis-treatment-to-medimetriks-300216786.html

    PR NEWS WIRE
    08 Feb 2016
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search